Goldman Sachs analyst Robert Cox raised the firm’s price target on Marsh McLennan (MMC) to $199 from $196 and keeps a Neutral rating on the shares. In a sector note on Americas Insurance, the firm said it expects “strong and fairly resilient” insurer profitability for the next few years, but added that it believes we are “solidly in the softening phase” of the P&C insurance cycle, which leads to “increased capital supply and competition, which should drive a deceleration in growth/pricing/margins, that we think are broadly underappreciated within Street estimates.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMC:
- Marsh McLennan price target lowered to $236 from $237 at Evercore ISI
- Marsh McLennan price target lowered to $226 from $242 at JPMorgan
- Marsh McLennan price target raised to $205 from $191 at Keefe Bruyette
- Marsh McLennan price target lowered to $174 from $181 at BofA
- Marsh McLennan to change NYSE symbol on January 14
